{"gene":"GPRASP3","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2004,"finding":"p60TRP (GPRASP3) contains a basic helix-loop-helix (bHLH) domain and physically interacts with Ran-binding protein 5 (RanBP5) and protein phosphatase 2A (PP2A), as demonstrated by yeast-two-hybrid and Western blotting analyses. It also influences NNT1 and p48ZnF signaling and is downregulated in the brain of Alzheimer's disease subjects.","method":"Bioinformatics, Western blotting, yeast two-hybrid system, PCR, fluorescence microscopy","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid and Western blotting from a single lab, two complementary methods identifying binding partners","pmids":["15034937"],"is_preprint":false},{"year":2004,"finding":"p60TRP was identified as a potential rescue factor against cell death induced by p18AβrP (p18-amyloid-beta-responsive protein) in PC12 cells, using a death trap method based on cDNA subtraction analysis.","method":"cDNA subtraction analysis, death trap method, PC12 cell overexpression","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method, limited mechanistic detail in abstract","pmids":["15333986"],"is_preprint":false},{"year":2004,"finding":"p60TRP-expressing cells compared with control cells during apoptosis showed differential expression; cDNA subtraction analysis identified p48ZnF (a zinc-finger protein) as upregulated in response to p60TRP expression context, suggesting p60TRP influences neuronal survival signaling linked to p48ZnF.","method":"cDNA subtraction analysis, PCR","journal":"Experimental & molecular medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, indirect association between p60TRP and p48ZnF, no direct binding demonstrated","pmids":["15150441"],"is_preprint":false},{"year":2011,"finding":"Overexpression of p60TRP in neural stem cells (NSCs) and transgenic mice modulates phosphorylation and proteolytic processing of APP, N-cadherin (Cdh2), presenilin (Psen), and tau (Mapt). p60TRP acts as an inhibitor of BACE1 and presenilin (the secretase complex), shifting APP processing toward the non-amyloidogenic pathway. p60TRP overexpression promoted neuroprotection (reduced apoptosis in Annexin-V, TUNEL, caspase-3/7 assays) and neurosynaptogenesis, and improved cognitive function in transgenic mice.","method":"NSC overexpression, p60TRP knockdown, transgenic mouse model, Annexin-V/TUNEL/caspase-3/7 apoptosis assays, radial arm water maze, Western blotting","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods from a single lab demonstrating inhibitory effect on BACE1/presenilin and neuroprotective functional outcome","pmids":["21199326"],"is_preprint":false},{"year":2013,"finding":"In vivo neuronal overexpression of p60TRP in transgenic mice causes significant alterations in the brain proteome of cortex and hippocampus (56 proteins significantly altered out of 1,735 quantified), supporting that p60TRP modulates cognitive and neuroprotective capacities at a systems level.","method":"iTRAQ-based quantitative proteomics, transgenic mouse model","journal":"Neuro-Signals","confidence":"Low","confidence_rationale":"Tier 3 / Weak — proteome-wide approach in a single lab; specific mechanistic links for individual proteins not established for GPRASP3 specifically","pmids":["23391701"],"is_preprint":false},{"year":2013,"finding":"p60TRP is described as a GPCR-associated sorting protein whose signaling involves RIN1, PP2A, RanBP5, CREB, and SYNJ1 pathways, and whose interference with the GPCR/secretase signaling pathway is proposed as a therapeutic target. The review consolidates experimental evidence that p60TRP functions in G protein signaling networks relevant to neurodegeneration.","method":"Review synthesizing prior experimental data (yeast two-hybrid, transgenic models)","journal":"Molecular neurobiology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — review/synthesis paper, no new primary experiments reported","pmids":["23345134"],"is_preprint":false},{"year":2014,"finding":"Deletion of a 0.35 Mb subregion of the mouse X chromosome containing Armcx5, Gprasp1, Gprasp2, and Bhlhb9 (GPRASP3) is sufficient to cause the Xq22.1 syndrome phenotype, including respiratory failure, cleft palate, neonatal lethality (males), and seizures with growth delay (females). This genetic epistasis establishes that loss of Bhlhb9/GPRASP3 (among the four genes) contributes causally to these developmental defects.","method":"Targeted chromosomal deletion in mouse, phenotypic analysis (respiratory failure, cleft palate, survival, seizure monitoring)","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean in vivo genetic deletion with defined phenotypic readouts; causality attributed to a four-gene subregion, not GPRASP3 alone","pmids":["24569167"],"is_preprint":false},{"year":2015,"finding":"Computational 3D structural modeling predicts that p60TRP forms a bHLH-domain-containing homodimer with a Mg2+-containing binding site, and in silico ligand docking identifies CB1954 and B73 as potential interacting small molecules at this site.","method":"Computational structure prediction (Modeller, I-TASSER, PROCHECK, ClusPro/PIPER), in silico ligand docking","journal":"Molecular informatics","confidence":"Low","confidence_rationale":"Tier 4 / Weak — purely computational, no experimental validation of structure or ligand binding reported","pmids":["27491919"],"is_preprint":false},{"year":2021,"finding":"GPRASP3 (GPRASP1, GPRASP2, GPRASP3/ARMCX subfamily 1) proteins possess armadillo-like repeats and interact with multiple GPCRs; GPRASP proteins participate in GPCR post-endocytic sorting. The review consolidates evidence that the subfamily 1 proteins (including GPRASP3) share structural features (armadillo repeats, additional repeated motifs) and interact with GPCRs, while subfamily 2 members are mitochondrially targeted.","method":"Review of in vitro and in vivo experiments across the family; GPRASP3-specific data includes structural domain annotation and family-level GPCR interaction context","journal":"Current topics in medicinal chemistry","confidence":"Low","confidence_rationale":"Tier 4 / Weak — review paper; GPRASP3-specific mechanistic experiments are not individually described, only family-level context","pmids":["33267763"],"is_preprint":false},{"year":2011,"finding":"RNA interference knockdown of Bhlhb9 (GPRASP3 ortholog) in prechondrocyte ATDC5 cells demonstrated a functional role for Bhlhb9 in chondrocyte differentiation, establishing it as one of five genes (out of 28 highly connected network genes tested) with a novel role in this developmental process.","method":"RNA interference in ATDC5 prechondrocyte cells, systems genetics network analysis","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct RNAi knockdown with defined cellular differentiation phenotype; single lab, single method","pmids":["20954177"],"is_preprint":false}],"current_model":"GPRASP3 (p60TRP/BHLHB9) is a bHLH domain-containing member of the GPRASP/ARMCX family that physically interacts with RanBP5 and PP2A, functions as an inhibitor of BACE1 and presenilin to shift APP processing toward the non-amyloidogenic pathway, promotes neuronal survival and synaptogenesis, and plays a role in chondrocyte differentiation; loss of the chromosomal subregion containing GPRASP3 causes respiratory failure, cleft palate, and seizures in mice, phenocopying human Xq22.1 deletion syndrome."},"narrative":{"mechanistic_narrative":"GPRASP3 (p60TRP/BHLHB9) is a bHLH domain-containing protein implicated in neuronal survival and the regulation of amyloid precursor protein (APP) processing [PMID:15034937, PMID:21199326]. It physically associates with Ran-binding protein 5 (RanBP5) and protein phosphatase 2A (PP2A) and acts within neuronal signaling networks relevant to neurodegeneration [PMID:15034937]. In neural stem cells and transgenic mice, GPRASP3 overexpression modulates the phosphorylation and proteolytic processing of APP, N-cadherin, presenilin, and tau, functioning as an inhibitor of BACE1 and the presenilin secretase complex to shift APP processing toward the non-amyloidogenic pathway; this is accompanied by reduced apoptosis, enhanced synaptogenesis, and improved cognitive performance [PMID:21199326]. Beyond its neuronal role, RNAi knockdown of the GPRASP3 ortholog impairs chondrocyte differentiation, indicating a developmental function [PMID:20954177]. In vivo, deletion of a chromosomal subregion containing GPRASP3 together with three neighboring genes produces respiratory failure, cleft palate, and seizures in mice, phenocopying human Xq22.1 deletion syndrome, though causality is attributed to the four-gene region rather than GPRASP3 alone [PMID:24569167]. The molecular basis of its BACE1/presenilin inhibition and the structural determinants of its partner interactions have not been experimentally resolved in the available corpus.","teleology":[{"year":2004,"claim":"Established the first molecular features of GPRASP3, defining it as a bHLH-domain protein with specific binding partners and linking it to Alzheimer's disease brain expression.","evidence":"Bioinformatics domain annotation, yeast two-hybrid and Western blotting identifying RanBP5 and PP2A binding in neuronal context","pmids":["15034937"],"confidence":"Medium","gaps":["Functional consequences of RanBP5 and PP2A binding not defined","Single-lab interaction data without reciprocal validation","Causal link to Alzheimer's pathology not established"]},{"year":2004,"claim":"Addressed whether GPRASP3 affects neuronal survival, positioning it as a candidate rescue factor against amyloid-beta-associated cell death.","evidence":"cDNA subtraction and death-trap overexpression screen in PC12 cells","pmids":["15333986","15150441"],"confidence":"Low","gaps":["Single method with limited mechanistic detail","No direct binding to death-pathway components shown","Association with p48ZnF is indirect"]},{"year":2011,"claim":"Defined a mechanistic role in APP processing by showing GPRASP3 inhibits BACE1 and presenilin to favor the non-amyloidogenic pathway, linking molecular activity to neuroprotection and cognition.","evidence":"NSC overexpression and knockdown, transgenic mice, apoptosis assays, behavioral testing, Western blotting","pmids":["21199326"],"confidence":"Medium","gaps":["Direct biochemical mechanism of secretase inhibition not resolved","Whether inhibition is direct or via intermediary partners unknown","Single-lab findings"]},{"year":2011,"claim":"Extended GPRASP3 function beyond neurons by demonstrating a requirement in chondrocyte differentiation.","evidence":"RNA interference knockdown in ATDC5 prechondrocyte cells with systems-genetics network analysis","pmids":["20954177"],"confidence":"Medium","gaps":["Molecular pathway in chondrogenesis not defined","Single method, single lab","Relationship to neuronal role unknown"]},{"year":2013,"claim":"Surveyed the systems-level consequences of GPRASP3 activity in vivo, supporting a broad modulatory role in cognitive and neuroprotective proteome states.","evidence":"iTRAQ quantitative proteomics of cortex and hippocampus in transgenic mice","pmids":["23391701"],"confidence":"Low","gaps":["Individual altered proteins not mechanistically tied to GPRASP3","Direct versus downstream effects not distinguished"]},{"year":2014,"claim":"Tested the in vivo developmental requirement of the GPRASP3 genomic region, establishing that its loss contributes to an Xq22.1-like syndrome.","evidence":"Targeted chromosomal deletion in mouse with phenotypic analysis of respiratory failure, cleft palate, lethality, and seizures","pmids":["24569167"],"confidence":"Medium","gaps":["Causality attributed to a four-gene region, not GPRASP3 alone","Single-gene contribution not isolated","Molecular pathway linking deletion to phenotype unknown"]},{"year":null,"claim":"The direct biochemical mechanism by which GPRASP3 inhibits BACE1/presenilin, and the structural and physiological basis of its GPCR and partner interactions, remain unresolved.","evidence":"No experimental structural or reconstitution data in the corpus","pmids":[],"confidence":"Low","gaps":["No experimentally validated structure","Direct enzyme-inhibition mechanism not reconstituted","GPCR sorting role for GPRASP3 specifically not experimentally isolated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0]}],"localization":[],"pathway":[],"complexes":[],"partners":["RANBP5","PP2A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6PI77","full_name":"G protein-coupled receptor associated sorting protein 3","aliases":["Protein BHLHb9","bHLHb9","Transcription regulator of 60 kDa","p60TRP"],"length_aa":547,"mass_kda":60.3,"function":"Survival and differentiation promoting protein that plays a role in the regulation of neurosynaptogenesis. Induces phosphatase PP2A activity which results in APP dephosphorylation and inhibits BACE1-mediated processing of APP","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q6PI77/entry"},"depmap":{"release":"DepMap","has_data":false,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPRASP3"},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GPRASP3","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GPRASP3"},"hgnc":{"alias_symbol":["p60TRP","KIAA1701","GASP3"],"prev_symbol":["BHLHB9"]},"alphafold":{"accession":"Q6PI77","domains":[{"cath_id":"-","chopping":"293-385","consensus_level":"high","plddt":80.0429,"start":293,"end":385},{"cath_id":"1.25.10.10","chopping":"395-547","consensus_level":"high","plddt":92.9168,"start":395,"end":547}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6PI77","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6PI77-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6PI77-F1-predicted_aligned_error_v6.png","plddt_mean":59.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPRASP3","jax_strain_url":"https://www.jax.org/strain/search?query=GPRASP3"},"sequence":{"accession":"Q6PI77","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6PI77.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6PI77/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6PI77"}},"corpus_meta":[{"pmid":"18089774","id":"PMC_18089774","title":"Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18089774","citation_count":75,"is_preprint":false},{"pmid":"15034937","id":"PMC_15034937","title":"Characterizing the new transcription regulator protein p60TRP.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15034937","citation_count":31,"is_preprint":false},{"pmid":"34807506","id":"PMC_34807506","title":"METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.","date":"2021","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34807506","citation_count":26,"is_preprint":false},{"pmid":"21199326","id":"PMC_21199326","title":"P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21199326","citation_count":23,"is_preprint":false},{"pmid":"23391701","id":"PMC_23391701","title":"Brain-site-specific proteome changes induced by neuronal P60TRP expression.","date":"2013","source":"Neuro-Signals","url":"https://pubmed.ncbi.nlm.nih.gov/23391701","citation_count":16,"is_preprint":false},{"pmid":"33267763","id":"PMC_33267763","title":"GPRASP/ARMCX Protein Family: Potential Involvement in Health and Diseases Revealed by their Novel Interacting Partners.","date":"2021","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33267763","citation_count":15,"is_preprint":false},{"pmid":"20954177","id":"PMC_20954177","title":"Systems genetics analysis of mouse chondrocyte differentiation.","date":"2011","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/20954177","citation_count":12,"is_preprint":false},{"pmid":"23345134","id":"PMC_23345134","title":"G proteins, p60TRP, and neurodegenerative diseases.","date":"2013","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23345134","citation_count":11,"is_preprint":false},{"pmid":"24569167","id":"PMC_24569167","title":"Respiratory failure, cleft palate and epilepsy in the mouse model of human Xq22.1 deletion syndrome.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24569167","citation_count":11,"is_preprint":false},{"pmid":"22172954","id":"PMC_22172954","title":"Neuronal p60TRP expression modulates cardiac capacity.","date":"2011","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/22172954","citation_count":8,"is_preprint":false},{"pmid":"27491919","id":"PMC_27491919","title":"3D Structure, Dimerization Modeling, and Lead Discovery by Ligand-protein Interaction Analysis of p60 Transcription Regulator Protein (p60TRP).","date":"2015","source":"Molecular informatics","url":"https://pubmed.ncbi.nlm.nih.gov/27491919","citation_count":8,"is_preprint":false},{"pmid":"15333986","id":"PMC_15333986","title":"[Possible mechanisms of A beta(1-40)- or A beta(1-42)-induced cell death and their rescue factors].","date":"2004","source":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","url":"https://pubmed.ncbi.nlm.nih.gov/15333986","citation_count":8,"is_preprint":false},{"pmid":"15150441","id":"PMC_15150441","title":"Nerve growth factor (NGF) induces mRNA expression of the new transcription factor protein p48ZnF.","date":"2004","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15150441","citation_count":6,"is_preprint":false},{"pmid":"33192735","id":"PMC_33192735","title":"Genome-Wide DNA Methylation Analysis in Male Methamphetamine Users With Different Addiction Qualities.","date":"2020","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33192735","citation_count":5,"is_preprint":false},{"pmid":"39324238","id":"PMC_39324238","title":"Identifying X-chromosome variants associated with age-related macular degeneration.","date":"2024","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39324238","citation_count":2,"is_preprint":false},{"pmid":"29972006","id":"PMC_29972006","title":"[Study of acupuncture combined with rat nerve growth factor on neurobehavioral ability of cerebral palsy infant rats and its brain tissue growth and metabolism associated proteins].","date":"2018","source":"Zhongguo zhen jiu = Chinese acupuncture & moxibustion","url":"https://pubmed.ncbi.nlm.nih.gov/29972006","citation_count":2,"is_preprint":false},{"pmid":"26854063","id":"PMC_26854063","title":"Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer.","date":"2016","source":"Cancer investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26854063","citation_count":1,"is_preprint":false},{"pmid":"37693625","id":"PMC_37693625","title":"Identifying X-Chromosome Variants Associated with Age-Related Macular Degeneration.","date":"2023","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37693625","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11054,"output_tokens":2498,"usd":0.035316,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9670,"output_tokens":2188,"usd":0.051525,"stage2_stop_reason":"end_turn"},"total_usd":0.086841,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"p60TRP (GPRASP3) contains a basic helix-loop-helix (bHLH) domain and physically interacts with Ran-binding protein 5 (RanBP5) and protein phosphatase 2A (PP2A), as demonstrated by yeast-two-hybrid and Western blotting analyses. It also influences NNT1 and p48ZnF signaling and is downregulated in the brain of Alzheimer's disease subjects.\",\n      \"method\": \"Bioinformatics, Western blotting, yeast two-hybrid system, PCR, fluorescence microscopy\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid and Western blotting from a single lab, two complementary methods identifying binding partners\",\n      \"pmids\": [\"15034937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"p60TRP was identified as a potential rescue factor against cell death induced by p18AβrP (p18-amyloid-beta-responsive protein) in PC12 cells, using a death trap method based on cDNA subtraction analysis.\",\n      \"method\": \"cDNA subtraction analysis, death trap method, PC12 cell overexpression\",\n      \"journal\": \"Nihon yakurigaku zasshi. Folia pharmacologica Japonica\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method, limited mechanistic detail in abstract\",\n      \"pmids\": [\"15333986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"p60TRP-expressing cells compared with control cells during apoptosis showed differential expression; cDNA subtraction analysis identified p48ZnF (a zinc-finger protein) as upregulated in response to p60TRP expression context, suggesting p60TRP influences neuronal survival signaling linked to p48ZnF.\",\n      \"method\": \"cDNA subtraction analysis, PCR\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, indirect association between p60TRP and p48ZnF, no direct binding demonstrated\",\n      \"pmids\": [\"15150441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Overexpression of p60TRP in neural stem cells (NSCs) and transgenic mice modulates phosphorylation and proteolytic processing of APP, N-cadherin (Cdh2), presenilin (Psen), and tau (Mapt). p60TRP acts as an inhibitor of BACE1 and presenilin (the secretase complex), shifting APP processing toward the non-amyloidogenic pathway. p60TRP overexpression promoted neuroprotection (reduced apoptosis in Annexin-V, TUNEL, caspase-3/7 assays) and neurosynaptogenesis, and improved cognitive function in transgenic mice.\",\n      \"method\": \"NSC overexpression, p60TRP knockdown, transgenic mouse model, Annexin-V/TUNEL/caspase-3/7 apoptosis assays, radial arm water maze, Western blotting\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal in vitro and in vivo methods from a single lab demonstrating inhibitory effect on BACE1/presenilin and neuroprotective functional outcome\",\n      \"pmids\": [\"21199326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In vivo neuronal overexpression of p60TRP in transgenic mice causes significant alterations in the brain proteome of cortex and hippocampus (56 proteins significantly altered out of 1,735 quantified), supporting that p60TRP modulates cognitive and neuroprotective capacities at a systems level.\",\n      \"method\": \"iTRAQ-based quantitative proteomics, transgenic mouse model\",\n      \"journal\": \"Neuro-Signals\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — proteome-wide approach in a single lab; specific mechanistic links for individual proteins not established for GPRASP3 specifically\",\n      \"pmids\": [\"23391701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"p60TRP is described as a GPCR-associated sorting protein whose signaling involves RIN1, PP2A, RanBP5, CREB, and SYNJ1 pathways, and whose interference with the GPCR/secretase signaling pathway is proposed as a therapeutic target. The review consolidates experimental evidence that p60TRP functions in G protein signaling networks relevant to neurodegeneration.\",\n      \"method\": \"Review synthesizing prior experimental data (yeast two-hybrid, transgenic models)\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — review/synthesis paper, no new primary experiments reported\",\n      \"pmids\": [\"23345134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Deletion of a 0.35 Mb subregion of the mouse X chromosome containing Armcx5, Gprasp1, Gprasp2, and Bhlhb9 (GPRASP3) is sufficient to cause the Xq22.1 syndrome phenotype, including respiratory failure, cleft palate, neonatal lethality (males), and seizures with growth delay (females). This genetic epistasis establishes that loss of Bhlhb9/GPRASP3 (among the four genes) contributes causally to these developmental defects.\",\n      \"method\": \"Targeted chromosomal deletion in mouse, phenotypic analysis (respiratory failure, cleft palate, survival, seizure monitoring)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean in vivo genetic deletion with defined phenotypic readouts; causality attributed to a four-gene subregion, not GPRASP3 alone\",\n      \"pmids\": [\"24569167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Computational 3D structural modeling predicts that p60TRP forms a bHLH-domain-containing homodimer with a Mg2+-containing binding site, and in silico ligand docking identifies CB1954 and B73 as potential interacting small molecules at this site.\",\n      \"method\": \"Computational structure prediction (Modeller, I-TASSER, PROCHECK, ClusPro/PIPER), in silico ligand docking\",\n      \"journal\": \"Molecular informatics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — purely computational, no experimental validation of structure or ligand binding reported\",\n      \"pmids\": [\"27491919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPRASP3 (GPRASP1, GPRASP2, GPRASP3/ARMCX subfamily 1) proteins possess armadillo-like repeats and interact with multiple GPCRs; GPRASP proteins participate in GPCR post-endocytic sorting. The review consolidates evidence that the subfamily 1 proteins (including GPRASP3) share structural features (armadillo repeats, additional repeated motifs) and interact with GPCRs, while subfamily 2 members are mitochondrially targeted.\",\n      \"method\": \"Review of in vitro and in vivo experiments across the family; GPRASP3-specific data includes structural domain annotation and family-level GPCR interaction context\",\n      \"journal\": \"Current topics in medicinal chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — review paper; GPRASP3-specific mechanistic experiments are not individually described, only family-level context\",\n      \"pmids\": [\"33267763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RNA interference knockdown of Bhlhb9 (GPRASP3 ortholog) in prechondrocyte ATDC5 cells demonstrated a functional role for Bhlhb9 in chondrocyte differentiation, establishing it as one of five genes (out of 28 highly connected network genes tested) with a novel role in this developmental process.\",\n      \"method\": \"RNA interference in ATDC5 prechondrocyte cells, systems genetics network analysis\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct RNAi knockdown with defined cellular differentiation phenotype; single lab, single method\",\n      \"pmids\": [\"20954177\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GPRASP3 (p60TRP/BHLHB9) is a bHLH domain-containing member of the GPRASP/ARMCX family that physically interacts with RanBP5 and PP2A, functions as an inhibitor of BACE1 and presenilin to shift APP processing toward the non-amyloidogenic pathway, promotes neuronal survival and synaptogenesis, and plays a role in chondrocyte differentiation; loss of the chromosomal subregion containing GPRASP3 causes respiratory failure, cleft palate, and seizures in mice, phenocopying human Xq22.1 deletion syndrome.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GPRASP3 (p60TRP/BHLHB9) is a bHLH domain-containing protein implicated in neuronal survival and the regulation of amyloid precursor protein (APP) processing [#0, #3]. It physically associates with Ran-binding protein 5 (RanBP5) and protein phosphatase 2A (PP2A) and acts within neuronal signaling networks relevant to neurodegeneration [#0]. In neural stem cells and transgenic mice, GPRASP3 overexpression modulates the phosphorylation and proteolytic processing of APP, N-cadherin, presenilin, and tau, functioning as an inhibitor of BACE1 and the presenilin secretase complex to shift APP processing toward the non-amyloidogenic pathway; this is accompanied by reduced apoptosis, enhanced synaptogenesis, and improved cognitive performance [#3]. Beyond its neuronal role, RNAi knockdown of the GPRASP3 ortholog impairs chondrocyte differentiation, indicating a developmental function [#9]. In vivo, deletion of a chromosomal subregion containing GPRASP3 together with three neighboring genes produces respiratory failure, cleft palate, and seizures in mice, phenocopying human Xq22.1 deletion syndrome, though causality is attributed to the four-gene region rather than GPRASP3 alone [#6]. The molecular basis of its BACE1/presenilin inhibition and the structural determinants of its partner interactions have not been experimentally resolved in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the first molecular features of GPRASP3, defining it as a bHLH-domain protein with specific binding partners and linking it to Alzheimer's disease brain expression.\",\n      \"evidence\": \"Bioinformatics domain annotation, yeast two-hybrid and Western blotting identifying RanBP5 and PP2A binding in neuronal context\",\n      \"pmids\": [\"15034937\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequences of RanBP5 and PP2A binding not defined\", \"Single-lab interaction data without reciprocal validation\", \"Causal link to Alzheimer's pathology not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Addressed whether GPRASP3 affects neuronal survival, positioning it as a candidate rescue factor against amyloid-beta-associated cell death.\",\n      \"evidence\": \"cDNA subtraction and death-trap overexpression screen in PC12 cells\",\n      \"pmids\": [\"15333986\", \"15150441\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single method with limited mechanistic detail\", \"No direct binding to death-pathway components shown\", \"Association with p48ZnF is indirect\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined a mechanistic role in APP processing by showing GPRASP3 inhibits BACE1 and presenilin to favor the non-amyloidogenic pathway, linking molecular activity to neuroprotection and cognition.\",\n      \"evidence\": \"NSC overexpression and knockdown, transgenic mice, apoptosis assays, behavioral testing, Western blotting\",\n      \"pmids\": [\"21199326\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical mechanism of secretase inhibition not resolved\", \"Whether inhibition is direct or via intermediary partners unknown\", \"Single-lab findings\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended GPRASP3 function beyond neurons by demonstrating a requirement in chondrocyte differentiation.\",\n      \"evidence\": \"RNA interference knockdown in ATDC5 prechondrocyte cells with systems-genetics network analysis\",\n      \"pmids\": [\"20954177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway in chondrogenesis not defined\", \"Single method, single lab\", \"Relationship to neuronal role unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Surveyed the systems-level consequences of GPRASP3 activity in vivo, supporting a broad modulatory role in cognitive and neuroprotective proteome states.\",\n      \"evidence\": \"iTRAQ quantitative proteomics of cortex and hippocampus in transgenic mice\",\n      \"pmids\": [\"23391701\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Individual altered proteins not mechanistically tied to GPRASP3\", \"Direct versus downstream effects not distinguished\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Tested the in vivo developmental requirement of the GPRASP3 genomic region, establishing that its loss contributes to an Xq22.1-like syndrome.\",\n      \"evidence\": \"Targeted chromosomal deletion in mouse with phenotypic analysis of respiratory failure, cleft palate, lethality, and seizures\",\n      \"pmids\": [\"24569167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causality attributed to a four-gene region, not GPRASP3 alone\", \"Single-gene contribution not isolated\", \"Molecular pathway linking deletion to phenotype unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The direct biochemical mechanism by which GPRASP3 inhibits BACE1/presenilin, and the structural and physiological basis of its GPCR and partner interactions, remain unresolved.\",\n      \"evidence\": \"No experimental structural or reconstitution data in the corpus\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimentally validated structure\", \"Direct enzyme-inhibition mechanism not reconstituted\", \"GPCR sorting role for GPRASP3 specifically not experimentally isolated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [],\n    \"pathway\": [],\n    \"complexes\": [],\n    \"partners\": [\"RanBP5\", \"PP2A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}